Want this question answered?
Catechol-O-methyltransferase (COMT) inhibitors are a class of medication used in combination with levodopa and carbidopa in the treatment of symptoms of Parkinson's disease (PD).
Times the given numbers together
-- Understand the question. -- Understand the information given with the question. -- Gather together all the information given, together with everything you know that talks about a connection between the question asked and the information given. -- Find a way to use what you know about the connection to find the answer to the question from the information given. -- The answer to the question that was asked is the 'solution' to the exercise.
To put two or more given values together.
0.1 and 0.8 added together.
Levodopa itself is not well tolerated, which is why it is combined with carbidopa. Carbidopa decreases peripheral metabolism of levodopa, which allows for lower doses of levodopa and less-severe side effects.
yes
The medication Levodopa or L-dopa often succeeds in lessening muscle rigidity and tremors , and is often given in conjunction with the drug Carbidopa
No, it is a purer form of the over the counter remedy 'Dopa Mucuna,' a mood enhancement suppliment; however, make no mistake, although Levodopa is over the counter it is still a psychoactive drug with potential side effects.
Although levodopa can cross our BBB, but it will be decarboxylated to dopamine peripherally before reaching our CNS - only small amount of Levodopa will be left and available to pass our BBB.So, instead of giving levodopa in high dose (which can cause lots of side effects), we give levodopa with peripheral decarboxylase inhibitors (e.g. carbidopa, benserazide) which can inhibit decarboxylation of levodopa in GIT and peripheral tissues. (By combining levodopa and peripheral decarobxylase inhibitors, we will have less side effects too)
nausea and vomiting low blood pressure, particularly when standing up, resulting in dizziness and fainting dyskinesias (abnormal movements including twisting and tics) in at least 50% of patients agitation hallucinations
pyridoxine (vitamin B6) can decrease the effect of levodopa.
Catechol-O-methyltransferase (COMT) inhibitors are a class of medication used in combination with levodopa and carbidopa in the treatment of symptoms of Parkinson's disease (PD).
the two most-commonly prescribed forms of levodopa include an amino-acid-decarboxylase (AADC) inhibitor: carbidopa (in Sinemet) or benzaseride (in Madopar).
Lack of L-dopa is the major problem. Therefore, symptoms improve with the use of the centrally-acting agent, levodopa (L-dopa), and the peripherally-acting agent, carbidopa.
Levodopa (Larodopa) is the mainstay of Parkinson's treatment. The drug crosses the blood-brain barrier, and is converted to dopamine. The drug may be administered alone, or in combination with carbidopa (Lodosyn)
Levodopa is a drug that helps to supplement dopamine, a neurotransmitter, to the brain of persons with PD.